Rxight™ From the Start

Rxight™ is a pharmacogenetic program designed by our founders, Matthew Rutledge and Denis Grizelj, that helps providers make a more informed prescribing decisions, helping their patients get the right medication at the right dose, right from the start, based on their genetic profile. Our genetic testing can provide critical insight into why some medications work better for certain people while others experience negative side effects. The article linked below discusses how pharmacogenetic testing is revolutionizing the treatment of mental health issues by offering evidence-based strategies for informing medication decisions. The approaches specified can reduce ineffective, or harmful course adjustments for conditions including schizophrenia, anxiety, and depression.

Read more here: https://www.jpn.ca/content/48/1/E11